1. Undiagnosed pneumonia - China (HU): RFI. Archive Number: 20191230.6864153 https://promedmail.org/promed-post/?id=6864153. (Available 2019-12-30 23:59:00)
2. Undiagnosed pneumonia - China (HU) (07): official confirmation of novel coronavirus. Archive Number: 20200108.6878869, https://promedmail.org/promed-post/?id=20200108.6878869. (Available 2020-01-08 23:19:25)
3. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet. 2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
4. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273. doi:10.1038/s41586-020-2012-7
5. Hoff mann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-280.e8. doi:10.1016/j.cell.2020.02.052
6. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032
7. Yang Х., Yu Y., Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8: 475-81
8. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-151. doi:10.3760/cma.j.issn.0254-6450.2020.02.003
9. Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China [published online ahead of print, 2020 Apr 10]. JAMA Neurol. 2020; e201127. doi:10.1001/jama-neurol.2020.1127
10. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffi th B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020; Mar 31. https://doi.org/10.1148/radi-ol.2020201187
11. Moriguchi T, Harii N, Goto J, et al. A first case of menin-gitis/encephalitis associated with SARS-Coronavirus-2 [published online ahead of print, 2020 Apr 3]. Int J Infect Dis. 2020;94:55-58. doi:10.1016/j.ijid.2020.03.062
12. Virani A., Rabold E., Hanson T. et al. Guillain-Barre Syndrome associated with SARS-CoV-2 infection IDCases Vol 20, 2020, e00771. http://creativecommons.org/licenses/by-nc-nd/4.0/
13. Giacomelli A, Pezzati L, Conti F, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study [published online ahead of print, 2020 Mar 26]. Clin Infect Dis. 2020; ciaa330. doi:10.1093/cid/ciaa330
14. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-rhino-laryngology: Official Journal of the European Federation of Oto-rhino-laryngological Societies (EUFOS): Affiliated with the German Society for Oto-rhino-laryngology - Head and Neck Surgery. 2020 Apr. DOI: 10.1007/s00405-020-05965-1
15. Nobel YR, Phipps M, Zucker J, Lebwohl B, Wang TC, Sobieszczyk ME, Freedberg DE, Gastrointestinal Symptoms and COVID-19: Case-Control Study from the United States, Gastroenterology (2020), doi: https://doi.org/10.1053/j.gastro.2020.04.017.
16. Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, Falck-Ytter Y, El-Serag HB, On behalf of the AGA, AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19, Gastroenterology (2020), doi: https://doi.org/10.1053/j.gastro.2020.05.001.
17. Hadi A, Werge M, Kristiansen KT, et al. Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members. Pancreatology. 2020;20(4):665-667. doi:10.1016/j.pan.2020.04.021
18. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective J Eur Acad Dermatol Venereol. 2020 Mar 26. https://doi.org/10.1111/JDV.16387
19. Casas C. G., Catala A., Hernandez G. C. et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020 Apr 29. doi: 10.1111/bjd.19163.
20. Klinicheskaya kcharakteristika kognych proayvlenij pri novoy koronavirusnoy infekcii COVID-19, vysvannoy SARS-CoV-2. [Clinical characteristics of skin manifestations with a new coronavirus infection COVID-19 caused by SARS-CoV-2] (online first, Russian Journal of Clinical Dermatology and Venereology = Klinicheskaya der-matologiya i venerologiya. 2020; 21(3). ISSN1997-2849 (Print), ISSN2309-4877 (Online) https://mosderm.ru/uploads/news/5eb5306b244d/5eb53960046e.pdf
21. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published correction appears in Lancet Respir Med. 2020 Apr;8(4): e26]. Lancet Respir Med. 2020;8(5):475-481. doi:10.1016/S2213-2600(20)30079-5
22. Wang D, Yin Y, Hu C, et al. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care. 2020;24(1):188. Published 2020 Apr 30. doi:10.1186/s13054-020-02895-6
23. Bangalore S, Sharma A, Slotwiner A, et al. ST-Segment Elevation in Patients with Covid-19 - A Case Series [published online ahead of print, 2020 Apr 17]. N Engl J Med. 2020; NEJMc2009020. doi:10.1056/NEJMc2009020
24. Zeng, J., Liu, Y., Yuan, J. et al. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection (2020). https://doi.org/10.1007/s15010-020-01424-5
25. Cizgici AY, Zencirkiran Agus H, Yildiz M. COVID-19 myopericarditis: It should be kept in mind in today's conditions [published online ahead of print, 2020 Apr 28]. Am J Emerg Med. 2020; S0735-6757(20)30310-7. doi:10.1016/j.ajem.2020.04.080
26. Inciardi RM, Lupi L, Zaccone G, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1096
27. Tung-Chen Y. Acute pericarditis due to COVID-19 infection: An underdiagnosed disease? [published online ahead of print, 2020 May 4]. Med Clin (Barc). 2020; S0025-7753(20)30257-8. doi:10.1016/j.medc-li.2020.04.007
28. Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369: m2094. Published 2020 Jun 3. doi:10.1136/bmj.m2094
29. Ramcharan T, Nolan O, Lai CY, et al. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital [published online ahead of print, 2020 Jun 12]. Pediatr Cardiol. 2020;1-11. doi:10.1007/s00246-020-02391-2
30. Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, Vol 395, 2020, p. 1054-1062, https://doi.org/10.1016/S0140-6736(20)30566-3.
31. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020. doi: https://doi.org/10.1111/jth.14830.
32. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 [published online ahead of print, 2020 Apr 10]. Thromb Res. 2020; S0049-3848(20)30120-1. doi:10.1016/j.thromres.2020.04.013
33. Dolhnikoff M., Duarte-Neto A.N., de Almeida Monteiro R. A. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. doi: 10.1111/JTH.14844
34. Li H., Liu L., Zhang D. et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. www.thelancet.com Published online April 17, 2020 https://doi.org/10.1016/S0140-6736(20)30920-X
35. Barnes BJ, Adrover JM, Baxter-Stoltzfus A, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020;217(6): e20200652. doi:10.1084/jem.20200652
36. Saghazadeh A., Rezaei N., Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids, International Immunopharmacology (2020), doi: https://doi.org/10.1016/j.intimp.2020.106560
37. Glybochko P, Fomin V, Avdeev S et al. Clinical characteristics of 1007 intensive care unit patients with SARS-CoV-2 pneumonia. Clin pharmacol ther 2020;29(2):21-29. https://clinpharm-journal.ru/articles/opublikovannye-onlajn/klinicheskaya-harakteristi-ka-1007-bolnyh-tyazheloj-sars-cov-2-pnevmoniej-nuzhdavshihsya-v-respiratornoj-podderzhke/?en=1
38. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series [published online ahead of print, 2020 Mar 30]. N Engl J Med. 2020; NEJMoa2004500. doi:10.1056/NEJMoa2004500
39. Barton L.M., MD, Duval E. J., Stroberg E. et al. COVID-19 Autopsies Oklahoma USA. American Journal of Clinical Pathology, Vol 153, Issue 6, p. 725-733, https://doi.org/10.1093/ajcp/aqaa062
40. Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020;220:1-13. doi:10.1016/j.trsl.2020.04.007
41. Buja LM, Wolf DA, Zhao B, et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities [published online ahead of print, 2020 May 7]. Cardiovasc Pathol. 2020;48:107233. doi:10.1016/j.carpath.2020.107233
42. Varga Z., Flammer A. J., Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet, Vol 395, 2020, https://doi.org/10.1016/S0140-6736(20)30937-5
43. Bhayana R., Som A., Li M. D. et al. Abdominal Imaging Findings in COVID-19: Preliminary Observations. Radiology May 11 2020, https://doi.org/10.1148/radiol.2020201908
44. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020;382(12):1177-1179. doi:10.1056/NEJMc2001737
45. Wolfel R., Corman V. M., Guggemos W. et al. Virological assessment of hospitalized patients with COVID-2019. Nature (2020). https://doi.org/10.1038/s41586-020-2196-x
46. Kolobuhina L. V. Klinika i lechenie grippa.[Clinic and treatment of influenza]. Regulayrnye vypuski « RMG», 2001, p.710 https://www.rmj.ru/archive/respiratornye_infektsii_urologiya_infektsii_i_invazii/
47. Henry B.M., Santos de Oliveira M. H., Benoit S. et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-anal-ysis. Clin Chem Lab Med 2020; https://doi.org/10.1515/cclm-2020-0369
48. Ruan Q., Yang K., Wang W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46, 846-848 (2020). https://doi.org/10.1007/s00134-020-05991-x
49. Velavan T. P., Meyer С. G. Mild versus severe COVID-19: Laboratory markers. International Journal of Infectious Diseases, Vol 95, 2020, p. 304-307, https://doi.org/10.1016/j.ijid.2020.04.061.
50. Fan J, Wang H, Ye G, et al. Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism. 2020;107:154243. doi:10.1016/j.metabol.2020.154243
51. Borchsenius SN, Chernova OA, Chernov VM, Vonskij MS. Mikoplazmy: molekularnaya i kletochnaya biologiya, vzaimodeystviye s immunnoy sistemoy mlekopitay-ushchikh, patogennost', diagnostica. [Mycoplasmas: molecular and cellular biology, interaction with the mammalian immune system, pathogenicity, diagnosis.] Science Publ., 2002, p. 28 https://www.rfbr.ru/rffi/ru/journal/o_66104.
52. Borchsenius SN, Chernova OA, Chernov VM, Vonskij MS. Mikoplazmy: molekularnaya i kletochnaya biologiya, vzaimodeystviye s immunnoy sistemoy mlekopitay-ushchikh, patogennost', diagnostica. [Mycoplasmas: molecular and cellular biology, interaction with the mammalian immune system, pathogenicity, diagnosis.] Science Publ., 2002, p. 40 https://www.rfbr.ru/rffi/ru/journal/o_66104
53. Borchsenius SN, Chernova OA, Chernov VM, Vishnyakov IE. Mikoplazmy v biologii i medicine na-chala XXI veka. [Mycoplasmas in biology and medicine at the beginning of the 21st century.] Science Publ., 2016, pp.175-176. https://www.rfbr.ru/rffi/ru/journal/o_1965595#1
54. Lu C-w, Liu X-f, Jia Z-f. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020, 395: e39. https://doi.org/10.1016/S0140-6736(20)30313-5
55. Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 2017;30(3):747-809. doi:10.1128/CMR.00114-16
56. Borchsenius SN, Chernova OA, Chernov VM, Vishnyakov IE. Mikoplazmy v biologii i medicine na-chala XXI veka. [Mycoplasmas in biology and medicine at the beginning of the 21st century.] Science Publ., 2016, pp.159-164
57. Quinti I, Lougaris V, Milito C, et al. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia [published online ahead of print, 2020 Apr 22]. J Allergy Clin Immunol. 2020; S0091-6749(20)30557-1. doi:10.1016/j.jaci.2020.04.013
58. Narita M. 2016. Classification of extrapulmonary manifestations due to Mycoplasma pneumoniae infection on the basis of possible pathogenesis. Front Microbiol 7:23. doi:10.3389/fmicb.2016.00023.
59. Gautret P, Lagier JC, Parola P, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. Travel Med Infect Dis. 2020;34:101663. doi:10.1016/j.tmaid.2020.101663
60. Damle B, Vourvahis M, Wang E, Leaney J, Corrigan B. Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19 [published online ahead of print, 2020 Apr 17]. Clin Pharmacol Ther. 2020;10.1002/cpt.1857. doi:10.1002/cpt.1857
61. Mayanskij A. N. Patogeneticheskaya mikrobiologia: ru-kovodstvo. [Pathogenetic microbiology: a guide.] Nizhny Novgorod, NizhGMA, Part 2, 2006, 44p. https://medread.ru/patogeneticheskaya-mikrobiologiya-2/44/
62. Khademi F, Vaez H, Momtazi-Borojeni AA, Majnooni A, Banach M, Sahebkar A. Bacterial infections are associated with cardiovascular disease in Iran: a meta-anal-ysis. Arch Med Sci. 2019;15(4):902-911. doi:10.5114/aoms.2019.85509
63. Roggerio A, Sambiase NV, Palomino SA, et al. Correlation of bacterial coinfection versus matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 expression in aortic aneurysm and atherosclerosis. Ann Vasc Surg. 2013;27(7):964-971. doi:10.1016/j.avsg.2013.02.012
64. Weiss TW, Schumacher S, Kaun C, et al. Association between smoking and presence of mycoplasma pneumoniae in circulating leukocytes. Swiss Med Wkly. 2010;140: w13105. Published 2010 Oct 7. doi:10.4414/smw.2010.13105
65. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and me-ta-analysis [published online ahead of print, 2020 May 27]. J Infect. 2020; S0163-4453(20)30323-6. doi:10.1016/j.jinf.2020.05.046
66. Zahariadis G., Gooley T. A., Ryall P. et al. Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: Variable incidence of atypical bacteria coinfection based on diagnostic assays. Can Respir J Vol 13 No 1, p17-22.
67. Fan BE, Lim KGE, Chong VCL, Chan SSW, Ong KH, Kuperan P. COVID-19 and mycoplasma pneumoniae coinfection. Am J Hematol. 2020;95(6):723-724. doi:10.1002/ajh.25785
68. Qin L, Chen Y, You X. Subversion of the Immune Response by Human Pathogenic Mycoplasmas. Front Microbiol. 2019;10:1934. Published 2019 Aug 21. doi:10.3389/fmicb.2019.01934
69. Ipoutcha T, Tsarmpopoulos I, Talenton V, et al. Multiple Origins and Specific Evolution of CRISPR/Cas9 Systems in Minimal Bacteria (Mollicutes). Front Microbiol. 2019;10:2701. Published 2019 Nov 21. doi:10.3389/fmicb.2019.02701
